Several Indian pharmaceutical firms are working on a coronavirus vaccine as part of global efforts to find a preventive to stem the spread of the deadly virus. Vaccines usually take years to develop and much longer to mass-produce, but scientists are hoping to have one ready in few months. As the number of coronavirus cases in the country continues to increase, the emphasis has shifted to vaccination. The Government of India is leading the fight against the COVID19 pandemic in partnership with the States and UTs. Vaccination is an important part of the Government of India's five-point plan for containing and managing the COVID19 pandemic, which also includes Test, Track, Treat, and COVID Appropriate Behaviour.
As of Monday morning, India had administered over 16.54 crore doses of the COVID-19 vaccine. However, in the midst of the outcry over vaccine shortages, and how many COVID-19 vaccines can these companies produce, and when will India be vaccinated is a big question.
List of Indian Pharma Companies Producing Covid 19 Vaccines:

| Pharma company | Name of Vaccine |
|---|---|
| SII | Covishield |
| Bharat Biotech | Covaxin |
| Biological E | Biological E |
| Zydus Cadila | ZyCoV-D |
| Hetero Biopharma | Sputinik V |
| Dr. Reddy's Laboratories | Sputnik V |
| Panacea Biotech | Covaxin |
| Gennova | HGCO19 |
| Mynvax | Mynvax |
| Hester Biosciences | - |
| Indian Immunologicals | - |
Poonawalla of SII had requested a government grant of Rs 3,000 crore to increase Covishield output beyond 100 million doses per month, which SII expects to meet by the end of May.
Biological E, Gennova, and SII have approached the Department of Biotechnology for help in accessing the Rs 900-crore Covid Suraksha fund set up by the Central government to speed up their vaccine growth.
Zydus Cadila's ZyCov-D, based in Ahmedabad, is one of the COVID-19 vaccines in phase 3 trials.
Biological E, based in Hyderabad, has agreed to produce 60 crore doses of Johnson & Johnson's COVID-19 vaccine per year under a contract manufacturing agreement.
Intranasal COVID-19 vaccine trials are also being conducted by Bharat Biotech.
Some companies are ready to launch their product, while others are either in the testing process or waiting for approval. We'll have to wait until they're available on the market. Covishield and Covaxin are currently available on the Indian market.
GoodReturns.in
More From GoodReturns

New PAN Card Rules From April 1, 2026: How To Apply For New PAN Card Via Protean, E-Filing Portal?

LPG Gas Cylinder Prices Hiked Again From April 1; 19 KG LPG Gets Costlier By Rs 218; 14.2 KG LPG Unchanged

Gold Rate in India Rises Over Rs 37,000/24K in Three Days; Will Jump in Gold Price Today Continue on 31 March?

Gas Cylinder Booking Rules: 5 Things To Know For Your 14.2Kg, 19KG, 5KG, 10KG LPG Booking In April 2026

Gold Rate Today Continues Rally, 24K Jumps Over Rs 35000 in 2 Days; 22K & 18K Gold, Silver Prices in Delhi

Bank Holiday In April 2026: Banks To Be Closed For 14 Days; Good Friday, Baisakhi To Akshaya Tritiya

Gold Price Today Declines After 3-Day Surge; Check Latest 22K, 24K, 18K Gold & Silver Rates in Delhi on 2April

Gold Price Today, April 3: 22K, 24K Rates Jump Across Tanishq, Malabar, Kalyan & Joyalukkas & IBJA

5 New Shares On One Soon: Anil Agarwal's Vedanta Demerger To Take Place in April, Says Report

Fresh Drop in Gold Rate Today; Silver Stable: Latest 22K, 24K, 18K Gold & Silver Prices in Delhi on 30 March

Govt Approves PDS Kerosene Distribution in 21 States for 60 Days, Sets 5,000 L Storage Limit Amid LPG Crisis



Click it and Unblock the Notifications